X-Biotix Therapeutics is Drug Discovery in United States that focus on novel small molecule business. Founded in 2016. They cover business area such as developer, novel small molecule antibiotic scaffold, antibiotic resistance, a pipeline, effective antibiotic, inhibitory activity, biological target, essential pathway, Gram-negative bacterial cell, doctor, effective antibody.
2016
( 10 years old in 2026 )
Novel Small Molecule
-
465 Waverley Oaks Road
Suite 414
Waltham, MA 02452
United States
Private
developernovel small molecule antibiotic scaffoldantibiotic resistancea pipelineeffective antibioticinhibitory activitybiological targetessential pathwayGram-negative bacterial celldoctoreffective antibody
* We use standard office opening hours in near X-Biotix Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
X-Biotix Therapeutics is Drug Discovery business from United States that founded in 2016 (10 years old in 2026), X-Biotix Therapeutics business is focusing on Novel Small Molecule.
X-Biotix Therapeutics headquarter office and corporate office address is located in 465 Waverley Oaks Road Suite 414 Waltham, MA 02452 United States.
X-Biotix Therapeutics was founded in United States.
In 2026, X-Biotix Therapeutics is currently focus on novel small molecule sector.
Above is snippet of Google Trends for "novel small molecule" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with X-Biotix Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
